0.14% of GDP, respectively, in 2010 (Panel 1 (a)(d) ).
Only 14% of adults were tertiary-qualified in 2003
(1 (s) ), and the share of S&T occupations is below the OECD average (1 (v) ). However, Argentina performs well in terms of human resources for innovation w h e n c o m p a re d t o o t h e r L a t i n A m e r i c a n economies. Relations between industry and public research institutions are weak (1 (o) ), but the share of patents with foreign co-inventors over 2007/09 is on a par with the leading OECD countries (1 (r) ). This reflects to some extent the small number of actors engaged in such activities. In terms of ICT infrastructures there are only 10 fixed broadband subscribers per 100 inhabitants (1 (k) ). The egovernment readiness index is among the lowest compared to the OECD area (1 (n) ). 
Recent changes in STI expenditures

Hot STI issues
• Focusing innovation policy on developing capabilities in high-impact priority areas and sectors: the agrisector, software, bio-and nano-technology, health and alternative energies.
• Increasing efforts to involve the private sector and other stakeholders in innovation policy design.
• Orienting R&D and innovation towards societal challenges, including inclusive development. P u b l i c a t i o n s i n t h e t o p -q u a r t i l e j o u r n a l s ( p e r G D P ) ( c )
Key figures
E -g o v e r n m e n t r e a d i n e s s i n d e x ( n ) I n d u s t r y -f i n a n c e d
P a t e n t s f i l e d b y u n i v e r s i t i e s a n d
I n t e r n a t i o n a l c o -p a t e n t i n g V e n t u r e c a p i t a l ( p e r G D P ) ( h ) P a t e n t i n g I n f ra s t r u c t u r e P l a n f o r S c i e n c e a n d
Top half OECD
Bottom half OECD
Technology 2008-11 allocated USD 97 million for the improvement and expansion of 50 research c e n t re s a n d a s
s o c i a t e d i n s t i t u t i o n s . T h e
Technology Platform Projects programme supports the establishment of centres of excellence with advanced facilities in the areas of genomics, proteomics and structural biology, stem cells, pre-clinical tests with experimental animals, new m a t e r i a l s , s o f t wa r e e n g i n e e r i n g a n d
bioinformatics. (2) Generic (2) Institutional block funding (3)
Clusters and regional policies:
Support to business R&D and innovation (4) Direct funding of business R&D (5) 
